Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Ornithine Aminotransferase ELISA Kit (AC3820)
Cat.#: ASET-2409
Specifications
Description Mouse Ornithine Aminotransferase ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Ornithine Aminotransferase concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.56 mU/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15-240 mU/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1782 Mouse Dopamine Transporter ELISA Kit (AC3193) Quantitative inquiry ASET-2382 Mouse CCR5 ELISA Kit (AC3793) Quantitative inquiry ASET-2159 Human HAAO ELISA Kit (AC3570) Quantitative inquiry ASET-2088 Canine Adenosine A1 Receptor ELISA Kit (AC3499) Quantitative inquiry ASET-1933 Human Aldolase C ELISA Kit (AC3344) Quantitative inquiry ASET-1844 Human PSD95 ELISA Kit (AC3255) Quantitative inquiry ASET-1319 Guinea Pig BDNF ELISA Kit (AC2730) Quantitative inquiry ASET-2321 Mouse Dehydroepiandrosterone ELISA Kit (AC3732) Quantitative inquiry ASET-1980 Human Serine Racemase ELISA Kit (AC3391) Quantitative inquiry ASET-1615 Human SOX10 ELISA Kit (AC3026) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket